- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Electra Therapeutics Inc (ETRA)
The Electra Therapeutics share price today is 7.31, view NASDAQ ETRA stock exchange data. Track the latest Electra Therapeutics share price with real-time updates on ETRA stock performance including market cap, day range, 52-week range and dividend yield. Access ETRA charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.06
8.38
52 wk Range
7.05
15.50
ETRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.068.38
52 wk Range
7.0515.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ETRA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
33.20
Upside
+354.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.20
(+354.17% Upside)
Earnings
Latest Release
28-08-2026
EPS / Forecast
-665.76 / --
Revenue / Forecast
-- / --
Compare ETRA to Peers and Sector
Metrics to compare | ETRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipETRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.8x | −3.0x | −0.2x | |
PEG Ratio | - | 0.01 | 0.00 | |
Price/Book | −2.1x | −0.9x | 2.6x | |
Price / LTM Sales | - | 11.6x | 2.8x | |
Upside (Analyst Target) | 354.2% | 1,003.6% | 65.5% | |
Fair Value Upside | Unlock | 24.3% | 8.9% | Unlock |
Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer. Its lead product candidate is ipsoprubart, that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, treatment for secondary hemophagocytic lymphohistiocytosis and T/NK Cell Malignancies; ELA822, a novel SIRP-specific monoclonal antibody for deplete activated T cells, treatment for T cell mediated immune disorders. Electra Therapeutics, Inc. was incorporated in 2018 and is based in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Electra Therapeutics (ETRA) Share Price Today?
The Electra Therapeutics share price today is 7.31.
What is the current Electra Therapeutics (ETRA) share price and day range?
As of 03-11-2026, the Electra Therapeutics share price is 7.31, with a previous close of 7.31. The share price has ranged from 7.06 to 8.38 today, while the 52-week range spans from 7.05 to 15.50.
What Is the Electra Therapeutics Market Cap?
As of today, Electra Therapeutics market cap is 458.83M.
What Is the Electra Therapeutics (ETRA) Share Price Target?
The average 12-month share price target for Electra Therapeutics is 33.20, with a high estimate of 36 and a low estimate of 30. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +354.17% Upside potential.
What Is Electra Therapeutics's Earnings Per Share (TTM)?
The Electra Therapeutics EPS (TTM) is -2,164.
From a Technical Analysis Perspective, Is ETRA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Electra Therapeutics Trade On?
Electra Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Electra Therapeutics?
The stock symbol for Electra Therapeutics is "ETRA."
How Many Times Has Electra Therapeutics Stock Split?
Electra Therapeutics has split 0 times.
How Many Employees Does Electra Therapeutics Have?
Electra Therapeutics has 46 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.